Eagle Asset Management Inc. Boosts Position in Avantor, Inc. (NYSE:AVTR)

Eagle Asset Management Inc. raised its holdings in shares of Avantor, Inc. (NYSE:AVTRGet Rating) by 0.6% during the fourth quarter, HoldingsChannel reports. The firm owned 2,872,821 shares of the company’s stock after purchasing an additional 17,393 shares during the period. Eagle Asset Management Inc.’s holdings in Avantor were worth $120,687,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Capital Advisors Ltd. LLC purchased a new position in Avantor during the 4th quarter valued at about $29,000. Quadrant Capital Group LLC increased its position in Avantor by 297.2% during the 4th quarter. Quadrant Capital Group LLC now owns 977 shares of the company’s stock valued at $41,000 after purchasing an additional 731 shares during the period. Altshuler Shaham Ltd purchased a new position in Avantor during the 3rd quarter valued at about $51,000. PrairieView Partners LLC increased its position in Avantor by 12,550.0% during the 4th quarter. PrairieView Partners LLC now owns 1,265 shares of the company’s stock valued at $53,000 after purchasing an additional 1,255 shares during the period. Finally, EverSource Wealth Advisors LLC purchased a new position in Avantor during the 4th quarter valued at about $55,000. 93.24% of the stock is currently owned by institutional investors and hedge funds.

AVTR traded up $0.92 during trading on Thursday, reaching $31.11. 5,928,486 shares of the company’s stock were exchanged, compared to its average volume of 5,092,077. Avantor, Inc. has a 1 year low of $28.64 and a 1 year high of $44.37. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.80 and a quick ratio of 1.18. The stock has a market capitalization of $18.99 billion, a P/E ratio of 34.67, a price-to-earnings-growth ratio of 0.65 and a beta of 1.53. The company’s fifty day simple moving average is $32.13 and its 200-day simple moving average is $35.83.

Avantor (NYSE:AVTRGet Rating) last posted its quarterly earnings results on Thursday, April 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. Avantor had a net margin of 7.72% and a return on equity of 32.17%. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.93 billion. During the same period last year, the firm posted $0.35 EPS. Avantor’s revenue for the quarter was up 9.2% compared to the same quarter last year. Equities analysts forecast that Avantor, Inc. will post 1.51 EPS for the current year.

AVTR has been the topic of a number of recent analyst reports. Cowen lowered their price target on shares of Avantor from $50.00 to $44.00 in a report on Tuesday, April 19th. Evercore ISI lowered their price target on shares of Avantor from $44.00 to $42.00 and set an “outperform” rating on the stock in a report on Monday, April 4th. William Blair restated an “outperform” rating on shares of Avantor in a report on Friday, April 29th. Morgan Stanley lowered their price target on shares of Avantor from $46.00 to $43.00 and set an “overweight” rating on the stock in a report on Monday, February 7th. Finally, Robert W. Baird lowered their price target on shares of Avantor from $44.00 to $43.00 in a report on Monday, February 7th. Two investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, Avantor currently has an average rating of “Buy” and a consensus price target of $43.13.

In other news, EVP Gerard Brophy sold 2,027 shares of Avantor stock in a transaction that occurred on Tuesday, March 1st. The shares were sold at an average price of $34.47, for a total transaction of $69,870.69. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.00% of the company’s stock.

About Avantor (Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRGet Rating).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.